4//SEC Filing
Gaiero David G 4
Accession 0001209191-24-004439
CIK 0001662244other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:11 PM ET
Size
15.0 KB
Accession
0001209191-24-004439
Insider Transaction Report
Form 4
Gaiero David G
Vice President, Finance
Transactions
- Exercise/Conversion
Common Stock
2024-02-29$1.68/sh+3,239$5,442→ 95,272 total - Exercise/Conversion
Common Stock
2024-02-29$1.69/sh+4,746$8,021→ 100,018 total - Exercise/Conversion
Common Stock
2024-03-04$1.69/sh+2,373$4,010→ 102,391 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−3,239→ 16,196 totalExercise: $1.68Exp: 2030-12-10→ Common Stock (3,239 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29−4,746→ 85,425 totalExercise: $1.69Exp: 2033-02-03→ Common Stock (4,746 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-04−2,373→ 83,052 totalExercise: $1.69Exp: 2033-02-03→ Common Stock (2,373 underlying)
Footnotes (2)
- [F1]The option vested as to 25% of the underlying shares of common stock on December 7, 2021, the first anniversary of the vesting commencement date, and vests as to 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.
- [F2]The option vests as to 1/48th of the underlying shares on each monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.
Documents
Issuer
Cyteir Therapeutics, Inc.
CIK 0001662244
Entity typeother
Related Parties
1- filerCIK 0001799784
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 6:11 PM ET
- Size
- 15.0 KB